Immunotherapy 15 (8), 553563
In a joint 2014 letter, the agencies concluded that "A pooled analysis of data from 14,611 patients with type 2 diabetes from 25 clinical trials in the sitagliptin database provided no compelling evidence of an increased risk of pancreatitis or pancreatic cancer" and "Both agencies agree that assertions concerning a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, as expressed recently in the scientific literature and in the media, are inconsistent with the current data
Why is my patient not losing weight while taking tirzepatide (Mounjaro) 7.5 mg weekly?
Related Reading Semaglutide For Weight Loss 2 Glp 1 Dosage For Weight Loss Semaglutide Tablets For Weight Loss Semaglutide Pills For Weight Loss Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Before use, it should be allowed to come to room temperature for a more comfortable injection experience
Sloot et al., 2019